Stockscreener 앱 받기
0.00
100.00%
-7.539
전일 마감가:
$7.539
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$11.99M
수익:
-
순이익/손실:
$-10.58M
주가수익비율:
0.00
EPS:
-9.49
순현금흐름:
$-6.79M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$23.73
Kintara Therapeutics Inc Stock (KTRA) Company Profile
명칭
Kintara Therapeutics Inc
전화
(858) 350-4364
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO
Kintara Therapeutics Inc 주식(KTRA)의 최신 뉴스
TuHURA Biosciences finalizes merger, sets Phase 3 trial - Investing.com India
Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - PR Newswire
HURA Stock Price and Chart — NASDAQ:HURA - TradingView
Lowenstein Represents Kintara Therapeutics in Merger with TuHURA Biosciences - Lowenstein Sandler LLP
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - AccessWire
Kintara approves 1-for-35 reverse stock split before merger - Investing.com India
Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 - PR Newswire
Kintara Therapeutics Announces Stock Split Amid Merger - TipRanks
Kintara approves reverse stock split, rebrands as TuHURA Biosciences - Investing.com India
Kintara announces 1-for-35 reverse stock split in connection with TuHURA merger - TipRanks
Kintara approves 1-for-35 reverse stock split before merger By Investing.com - Investing.com South Africa
Kintara approves reverse stock split, rebrands as TuHURA Biosciences By Investing.com - Investing.com Australia
Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - Quantisnow
Kintara Therapeutics Inc (KTRA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - PR Newswire
Kintara amends CVR issuance terms ahead of TuHURA merger By Investing.com - Investing.com Canada
Kintara amends CVR issuance terms ahead of TuHURA merger - Investing.com India
The Significance of Moving Averages in Kintara Therapeutics Inc Inc. (KTRA) Price Performance - The InvestChronicle
Market Highlights: Kintara Therapeutics Inc (KTRA) Ends on a High Note at 0.20 - The Dwinnex
Kintara stock climbs 10% on TuHURA merger update (NASDAQ:KTRA) - Seeking Alpha
Kintara Therapeutics Inc (KTRA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Stockholders Fail to Approve Proposal to Reincorporate Nevada Corporation in Delaware - The National Law Review
Kintara Therapeutics Reveals Improved Financials, Merger Plans - Yahoo Finance
Ratios Reveal: Breaking Down Kintara Therapeutics Inc (KTRA)’s Financial Health - The Dwinnex
Are Kintara Therapeutics Inc (KTRA) shares a good deal now? - US Post News
Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update - PR Newswire
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update - GuruFocus.com
Kintara shareholders approve key proposals; Charter change fails - Investing.com
Kintara shareholders approve key proposals; Charter change fails By Investing.com - Investing.com Australia
This trade activity should not be overlooked: Kintara Therapeutics Inc (KTRA) - SETE News
Financial Metrics Unveiled: Kintara Therapeutics Inc (KTRA)’s Key Ratios in the Spotlight - The Dwinnex
Kintara Therapeutics modifies merger terms with TuHURA Biosciences By Investing.com - Investing.com Canada
Kintara Therapeutics Inc Inc. (KTRA) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Kintara Therapeutics modifies merger terms with TuHURA Biosciences - Investing.com India
Kinross Gold (NYSE:KGC) Lowered to Buy at StockNews.com - Defense World
Kintara Therapeutics announces special stockholder meeting - Investing.com
Viking Therapeutics Unusual Options Activity For September 24 - Benzinga
Results from Kintara Therapeutics Inc (KTRA) show risk - US Post News
Kintara Urges Shareholder Votes for TuHURA Biosciences Merger - TipRanks
Viking Therapeutics (NASDAQ:VKTX) Rating Increased to Sell at StockNews.com - MarketBeat
Kintara Therapeutics (NASDAQ:KTRA) Shares Down 6.3% - Defense World
Kaival Brands Shares More Than Double on Delta Corp Holdings Merger - MarketWatch
Viking Therapeutics (NASDAQ:VKTX) Trading Down 3% After Insider Selling - MarketBeat
Knight-Swift Transportation Holdings Inc. (NYSE:KNX) is Interval Partners LP's 10th Largest Position - MarketBeat
Balance Sheet Insights: Kintara Therapeutics Inc (KTRA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Kintara delays special meeting vote on key proposals By Investing.com - Investing.com Canada
Viking therapeutics CEO sells over $15m in company stock By Investing.com - Investing.com Australia
Viking therapeutics director sells shares worth over $715,000 - Investing.com
Viking therapeutics director sells shares worth over $715,000 By Investing.com - Investing.com UK
Kintara Therapeutics Inc (KTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):